Skip to main content

Lumigan News

Allergan, Inc. Receives FDA Approval for Lumigan 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients

IRVINE, Calif.--(BUSINESS WIRE)--Aug 31, 2010 - Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved Lumigan (bimatoprost ophthalmic solution) 0.01% as a...

FDA Medwatch Alert: Age Intervention Eyelash

[Posted 11/19/2007] FDA informed healthcare professionals and consumers of the seizure of 12,682 applicator tubes of Age Intervention Eyelash, sold and distributed by Jan Marini Skin Research, Inc....

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Glaucoma (Open Angle)

Lumigan patient information at Drugs.com